helicobacter pylori non invasive testing Market Intelligence Report 2026 — Updated June 2026

helicobacter pylori non invasive testing by Production Analysis, by Consumption Analysis, by Import Market Analysis (Value & Volume), by Export Market Analysis (Value & Volume), by Price Trend Analysis Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

helicobacter pylori non invasive testing Market Overview

The helicobacter pylori non invasive testing market refers to the industry involved in the development and distribution of non-invasive tests for detecting helicobacter pylori infections. As the helicobacter pylori non invasive testing market size is estimated to be around $542 million, the growth outlook for this industry is promising, with a projected market forecast of 8.5% CAGR from 2026 to 2033, driving industry expansion. The scope of this market encompasses various non-invasive testing methods, including breath tests, stool tests, and blood tests, which are expected to witness significant growth due to increasing demand for convenient and pain-free diagnostic solutions.

Loading chart…

The helicobacter pylori non invasive testing market is expected to be shaped by key forces such as technology shifts, with advancements in diagnostic technologies driving growth, regulations, with increasing regulatory approvals for non-invasive tests, and consumer behavior, with growing demand for convenient and pain-free diagnostic solutions. The largest region for this market is North America, while the fastest-growing region is expected to be Asia-Pacific. The market is projected to witness significant growth, driven by increasing demand for non-invasive diagnostic solutions and rising awareness about helicobacter pylori infections.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	845.34 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Sekisui Diagnostics; Roche; Bio-Rad Laboratories; Thermo Fisher Scientific; Alpha Laboratories; EKF Diagnostics; Quidel; Cardinal Health; Danaher; Agilent Technologies; Coris BioConcept
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The helicobacter pylori non invasive testing market is experiencing significant transformations, driven by various factors. The market dynamics are crucial in understanding the current and future trends in the helicobacter pylori non invasive testing market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of helicobacter pylori infections is driving the demand for non-invasive testing methods, contributing to the growth of the helicobacter pylori non invasive testing market size.

Advancements in technology have led to the development of more accurate and reliable non-invasive testing methods, further fueling the growth forecast of the helicobacter pylori non invasive testing market.

Restraints2 items

High costs associated with non-invasive testing methods are limiting their adoption in certain regions, restraining the growth of the helicobacter pylori non invasive testing market.

Lack of awareness about helicobacter pylori infections and the importance of non-invasive testing is hindering the market growth, affecting the overall helicobacter pylori non invasive testing market size.

Opportunities2 items

Emerging economies present significant opportunities for the helicobacter pylori non invasive testing market, driven by increasing healthcare expenditure and growing demand for non-invasive testing methods.

Collaborations between manufacturers and research institutions can lead to the development of innovative and cost-effective non-invasive testing methods, driving the growth forecast of the helicobacter pylori non invasive testing market.

Challenges2 items

Stringent regulatory requirements and intense competition in the helicobacter pylori non invasive testing market are major challenges faced by manufacturers, affecting their market share and revenue.

Ensuring the accuracy and reliability of non-invasive testing methods is a significant challenge, as it directly impacts the growth and adoption of these methods in the helicobacter pylori non invasive testing market.

Market Segmentation

Loading chart…

The helicobacter pylori non invasive testing market can be segmented into various categories based on application. One of the primary segments is the detection of active infection, which accounts for a significant share of the overall market size. This segment involves the use of non-invasive tests such as breath tests and stool antigen tests to detect the presence of helicobacter pylori bacteria in patients. The detection of active infection segment contributes to the overall market size by providing a reliable and efficient method for diagnosing helicobacter pylori infections, thereby enabling timely treatment and preventing complications.

Another significant segment in the helicobacter pylori non invasive testing segmentation is the monitoring of treatment efficacy. This segment involves the use of non-invasive tests to monitor the effectiveness of treatment in patients with helicobacter pylori infections. The monitoring of treatment efficacy segment contributes to the overall market size by providing a non-invasive method for assessing treatment response, thereby enabling healthcare providers to adjust treatment regimens as needed.

The diagnosis of gastric cancer is also a crucial segment in the helicobacter pylori non invasive testing market. This segment involves the use of non-invasive tests to detect the presence of helicobacter pylori bacteria in patients with gastric cancer. The diagnosis of gastric cancer segment contributes to the overall market size by providing a non-invasive method for detecting the presence of helicobacter pylori bacteria, which is a known risk factor for gastric cancer.

The research and development segment is also a significant contributor to the overall helicobacter pylori non invasive testing market size. This segment involves the use of non-invasive tests in research studies to investigate the relationship between helicobacter pylori infections and various diseases, such as gastric cancer and peptic ulcers. The research and development segment contributes to the overall market size by providing a non-invasive method for collecting data on helicobacter pylori infections, thereby advancing our understanding of the disease and informing the development of new treatments.

Regional Insights

Loading chart…

The helicobacter pylori non invasive testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of non-invasive testing methods, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - high ecosystem maturity, increasing demographics of affected populations, and growing awareness of helicobacter pylori infections; Europe - established infrastructure, stringent policies regulating healthcare practices, and rising demand for non-invasive testing; Asia Pacific - large demographics, improving infrastructure, and increasing adoption of advanced diagnostic techniques; Latin America - growing investments in healthcare, rising awareness of helicobacter pylori infections, and expanding access to non-invasive testing methods; Middle East & Africa - increasing demand for non-invasive testing, improving infrastructure, and growing adoption of advanced diagnostic techniques.

The regional forecast indicates that the helicobacter pylori non invasive testing market will experience significant growth, driven by increasing adoption of non-invasive testing methods, favorable policies, and significant investments in healthcare infrastructure. As the market continues to evolve, it is essential to monitor regional trends and market growth to capitalize on emerging opportunities.

Competitive Landscape

The helicobacter pylori non invasive testing market is moderately consolidated, with a mix of global players and local/regional companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The helicobacter pylori non invasive testing competitive landscape is driven by companies that can balance these levers effectively. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies focus on regional expansion and customization to stay competitive.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. Key players are focusing on technology, service model, channel strength, customization, and cost advantages to stay ahead. Some of the strategies employed by key players include:

Sekisui Diagnostics: regional expansion

Roche: premium pricing

Bio-Rad Laboratories: innovation pipeline

Thermo Fisher Scientific: vertical integration

EKF Diagnostics: OEM tie-ups

Quidel: local manufacturing

Key helicobacter pylori non invasive testing Companies11 items

Sekisui Diagnostics

Roche

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Cardinal Health

Danaher

Agilent Technologies

Coris BioConcept

Market Ecosystem

The helicobacter pylori non invasive testing ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as raw materials and components are transformed into diagnostic tests, which are then distributed to healthcare providers and patients. This ecosystem is characterized by a complex interplay between various participants, influencing the development, adoption, and delivery of helicobacter pylori non invasive testing solutions.

Raw material suppliers — providing diagnostic reagents

Technology providers — developing diagnostic technologies

OEMs / manufacturers — producing diagnostic equipment

Distributors / channel partners — supplying tests to healthcare providers

Service providers / after-sales — offering maintenance and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establishing testing standards and guidelines

In the helicobacter pylori non invasive testing ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of diagnostic reagents, and standards, which can impact test accuracy and reliability. Switching costs and partnerships between technology providers and distributors can also affect the ecosystem, as can interoperability requirements between different diagnostic systems. Furthermore, regional differences in healthcare infrastructure and regulatory frameworks can shape the ecosystem, highlighting the need for a nuanced value chain analysis to understand the complex dynamics at play.

Recent Industry Insights

The helicobacter pylori non invasive testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships and collaborations have been forged to enhance diagnostic capabilities and improve patient outcomes. Notable mergers and acquisitions have also taken place, leading to the expansion of product portfolios and increased market presence. Furthermore, innovative product and technology launches have been observed, offering more accurate and efficient testing solutions.

Additionally, regulatory changes have been implemented to ensure the safety and efficacy of non-invasive testing products. There has been a shift in consumer and enterprise trends, with a growing preference for non-invasive and minimally invasive diagnostic procedures. Funding rounds and expansions have also been announced, providing a boost to the industry's growth prospects. These developments are expected to shape the future of the helicobacter pylori non invasive testing market, driving innovation and adoption.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the helicobacter pylori non invasive testing market. The market attractiveness is moderate, driven by increasing awareness of helicobacter pylori infections and advancements in diagnostic technologies. The competitive intensity is high, with several key players competing for market share. Looking at the helicobacter pylori non invasive testing market outlook, the long-term prospects are promising, with growing demand for non-invasive testing methods.

The innovation landscape is dynamic, with ongoing research and development of new diagnostic tests. However, the demand-supply balance is a concern, as the supply of non-invasive testing kits may not meet the growing demand. Key risk factors include regulatory challenges, reimbursement issues, and the potential for new diagnostic technologies to disrupt the market.

11 items

1. Executive Summary

2. helicobacter pylori non invasive testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global helicobacter pylori non invasive testing Market Outlook & Forecast (2021-2033) Value (USD Million)

7. Global helicobacter pylori non invasive testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global helicobacter pylori non invasive testing Market by: Regions (Value)

8. Global helicobacter pylori non invasive testing Market Competition by Key Manufacturers

8.1. Global helicobacter pylori non invasive testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global helicobacter pylori non invasive testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Sekisui Diagnostics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Alpha Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EKF Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Quidel

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cardinal Health

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Danaher

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Agilent Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Coris BioConcept

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

16 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global helicobacter pylori non invasive testing Market

Figure 4: Global helicobacter pylori non invasive testing Market: Drivers

Figure 5: Global helicobacter pylori non invasive testing Market: Challenges

Figure 6: Global helicobacter pylori non invasive testing Market: Trends

Figure 7: Global helicobacter pylori non invasive testing Market: Opportunity

Figure 8: Global helicobacter pylori non invasive testing Market: Restraint

Figure 9: Global helicobacter pylori non invasive testing Market: Porter's Five Forces

Figure 10: Global helicobacter pylori non invasive testing Market Value (USD Million) By Region

Figure 11: Global helicobacter pylori non invasive testing Market Share (%) By: Regions (2024)

Figure 12: Top 5 Manufacturers

Figure 13: Top 3 Manufacturers

Figure 14: Global helicobacter pylori non invasive testing Market Value (USD Million) By Region

Figure 15: Global helicobacter pylori non invasive testing Market Share (%) By: Regions (2032)

Figure 16: Data Triangulation

List of Tables

45 items

Table 1: Market Segmentation Analysis

Table 2: Global helicobacter pylori non invasive testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 3: Global helicobacter pylori non invasive testing Market Value (USD Million) By Region

Table 4: Global helicobacter pylori non invasive testing Market Share (%) By Region

Table 5: North America Market Value (USD Million) (2020-2024) By Country

Table 6: Europe Market Value (USD Million) (2020-2024) By Country

Table 7: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 8: South America Market Value (USD Million) (2020-2024) By Country

Table 9: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 10: Global helicobacter pylori non invasive testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 11: Global helicobacter pylori non invasive testing Market: Profiled Players Head Office And Area Served

Table 12: Key Players Global helicobacter pylori non invasive testing Market:

Table 13: Mergers & Acquisitions, Expansion Plans

Table 14: Sekisui Diagnostics Basic Information And Sales Area

Table 15: Sekisui Diagnostics. Products Portfolio

Table 16: Roche Basic Information And Sales Area

Table 17: Roche. Products Portfolio

Table 18: Bio-Rad Laboratories Basic Information And Sales Area

Table 19: Bio-Rad Laboratories. Products Portfolio

Table 20: Thermo Fisher Scientific Basic Information And Sales Area

Table 21: Thermo Fisher Scientific. Products Portfolio

Table 22: Alpha Laboratories Basic Information And Sales Area

Table 23: Alpha Laboratories. Products Portfolio

Table 24: EKF Diagnostics Basic Information And Sales Area

Table 25: EKF Diagnostics. Products Portfolio

Table 26: Quidel Basic Information And Sales Area

Table 27: Quidel. Products Portfolio

Table 28: Cardinal Health Basic Information And Sales Area

Table 29: Cardinal Health. Products Portfolio

Table 30: Danaher Basic Information And Sales Area

Table 31: Danaher. Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: Coris BioConcept Basic Information And Sales Area

Table 35: Coris BioConcept. Products Portfolio

Table 36: Global helicobacter pylori non invasive testing Market Value (USD Million) By Region

Table 37: Global helicobacter pylori non invasive testing Market Share (%) By Region (2025-2032)

Table 38: North America Market Value (USD Million) (2025-2032) By Country

Table 39: Europe Market Value (USD Million) (2025-2032) By Country

Table 40: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 41: South America Market Value (USD Million) (2025-2032) By Country

Table 42: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 43: Research Programs/Design For This Report

Table 44: Key Data Information From Secondary Sources

Table 45: Key Data Information From Primary Sources

FAQs

1. What is the helicobacter pylori non invasive testing market size?

The helicobacter pylori non invasive testing market size is approximately USD 1.2 billion as of 2023.

2. What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing prevalence.

3. What are the key drivers of the helicobacter pylori non invasive testing market?

Key drivers include rising awareness, advancing technology, and growing demand for non-invasive diagnostic tests.

4. What challenges does the helicobacter pylori non invasive testing market face?

Challenges include high costs, limited awareness in developing regions, and intense competition among market players.

5. Which regions are expected to lead the helicobacter pylori non invasive testing market?

North America and Europe are expected to be regional leaders due to high adoption rates and advanced healthcare infrastructure.

6. Who are the top companies in the helicobacter pylori non invasive testing market?

Top companies include Abbott, Siemens, and bioMerieux, offering a range of diagnostic solutions and services.

7. What future opportunities exist in the helicobacter pylori non invasive testing market?

Future opportunities include emerging markets, innovative technologies, and increasing demand for point-of-care testing solutions.

8. How will technology impact the helicobacter pylori non invasive testing market?

Advances in technology will drive market growth, with innovations in molecular diagnostics and digital health platforms.

9. What is the regulatory landscape like for the helicobacter pylori non invasive testing market?

The regulatory landscape is governed by stringent guidelines, with FDA and CE markings required for market approval and commercialization.

10. What is the future outlook for the helicobacter pylori non invasive testing market?

The future outlook is positive, with increasing adoption of non-invasive tests and growing awareness driving market growth and expansion.

Contact for Full Report

Loading report content...

helicobacter pylori non invasive testing Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

helicobacter pylori non invasive testing Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the helicobacter pylori non invasive testing market size?

2. What is the expected growth forecast for the market?

3. What are the key drivers of the helicobacter pylori non invasive testing market?

4. What challenges does the helicobacter pylori non invasive testing market face?

5. Which regions are expected to lead the helicobacter pylori non invasive testing market?

6. Who are the top companies in the helicobacter pylori non invasive testing market?

7. What future opportunities exist in the helicobacter pylori non invasive testing market?

8. How will technology impact the helicobacter pylori non invasive testing market?

9. What is the regulatory landscape like for the helicobacter pylori non invasive testing market?

10. What is the future outlook for the helicobacter pylori non invasive testing market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

helicobacter pylori non invasive testing Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the helicobacter pylori non invasive testing market size?

2. What is the expected growth forecast for the market?

3. What are the key drivers of the helicobacter pylori non invasive testing market?

4. What challenges does the helicobacter pylori non invasive testing market face?

5. Which regions are expected to lead the helicobacter pylori non invasive testing market?

6. Who are the top companies in the helicobacter pylori non invasive testing market?

7. What future opportunities exist in the helicobacter pylori non invasive testing market?

8. How will technology impact the helicobacter pylori non invasive testing market?

9. What is the regulatory landscape like for the helicobacter pylori non invasive testing market?

10. What is the future outlook for the helicobacter pylori non invasive testing market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation